We are live on
!
Find out more
EUCRU
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
EUCRU
Delisted
EUCRU was delisted on the 26th of April, 2023.
17 hedge funds and large institutions have $41.2M invested in Eucrates Biomedical Acquisition Corp. Unit in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
6% more capital invested
Capital invested by funds: $38.9M → $41.2M (+$2.37M)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
11% less funds holding
Funds holding: 19 → 17 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Holders
17
Holders Change
-2
Holders Change %
-10.53%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
3
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
WC
Wealthspring Capital
West Harrison,
New York
|
+$86.4K |
| 2 |
SMA
Sage Mountain Advisors
Atlanta,
Georgia
|
+$26.5K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$300 |
Top Sellers
| 1 |
Millennium Management
New York
|
-$816K |
| 2 |
SCM
Sio Capital Management
New York
|
-$513K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$11.1K |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
-$889 |
